Callio Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
May 18, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Callio Therapeutics is focused on advancing a multi-payload antibody-drug conjugate platform through clinical proof-of-concept.
Market
Pharmaceuticals
Location
United States

Links
Back to Home Back to Biotechnology Deals View Funding Announcement